Rating History for Phathom Pharmaceuticals (PHAT) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/27/2026 | Glen Santangelo | Upgrade | Overweight (Equalweight) |
18.00 (16.00) |
10.47 (11.95) |
14.14% | Details |
 |
|||||||
